Sarissa Capital Management as of Dec. 31, 2023
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 9 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 28.9 | $188M | 16M | 11.44 | |
| Biogen Idec (BIIB) | 25.6 | $166M | 643k | 258.77 | |
| Innoviva (INVA) | 18.0 | $117M | 7.3M | 16.04 | |
| Gilead Sciences (GILD) | 13.4 | $87M | 1.1M | 81.01 | |
| Neurocrine Biosciences (NBIX) | 9.5 | $62M | 470k | 131.76 | |
| Amarin Corp Spons Adr New (AMRN) | 3.3 | $22M | 25M | 0.87 | |
| BioCryst Pharmaceuticals (BCRX) | 0.9 | $6.0M | 1.0M | 5.99 | |
| Vor Biopharma (VOR) | 0.2 | $1.4M | 618k | 2.25 | |
| Regulus Therapeutics (RGLS) | 0.0 | $237k | 185k | 1.28 |
